This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TherapeuticsMD Appoints Joel S. Krasnow, M.D. As Chief Scientific Officer

Dr. Krasnow joins TherapeuticsMD from Intarcia Therapeutics, where as Chief Safety Officer he was responsible for managing and conducting ongoing safety surveillance on the Intarcia Therapeutics' products, including its lead diabetes product. He also provided scientific input to leverage Intarcia Therapeutics' technology across different clinical applications.

Prior to Intarcia Therapeutics, at Eisai Pharmaceuticals, Dr. Krasnow was promoted to Vice President and Chief Medical Officer of its Frontier Business Unit, where he led clinical development, provided clinical guidance to discovery projects and evaluated in-licensing opportunities. He previously spent over four years in the areas of immunology and metabolism at Hoffman-LaRoche, where as the Clinical Science Leader he led the analysis, reporting and presentation of the clinical data resulting in global product approvals for a monoclonal antibody to the interleukin-6 receptor Actemra ® (Tocilizumab), as well as the clinical development and medical marketing of Boniva ® (Ibandronate). He also worked at Novartis as the Senior Medical Director in the Arthritis and Bone Division leading to the registration of Reclast ® (Zoledronic Acid) for Paget’s disease and osteoporosis. During his four year tenure as Medical Director of Pfizer’s Global Prescription Business, he managed clinical and medical marketing programs for contraceptive and hormone replacement products. At Organon, he rose to Medical Director, Endocrinology and Women’s Health, and was the Clinical Lead for FDA interactions with Antagon ® (Ganirelix) and Mircette ®. He also worked at Deloitte Consulting as a Senior Consultant in Pharmaceutical and Managed Care and as a Medical Advisor at Blue Cross of Western Pennsylvania.

Dr. Krasnow received his Doctor of Medicine degree from McGill University School of Medicine in Montreal, Canada, and his Masters of Business Administration from the Katz Graduate School of Business at the University of Pittsburgh. He was a Fellow in the Department of Reproductive Endocrinology at Baylor College of Medicine in Houston, Texas, and spent his residency in the Department of Obstetrics and Gynecology at the University of Chicago.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.73 -1.20%
FB $117.51 0.67%
GOOG $694.26 0.47%
TSLA $240.91 -2.70%
YHOO $36.65 0.16%


Chart of I:DJI
DOW 17,778.54 -52.22 -0.29%
S&P 500 2,063.56 -12.25 -0.59%
NASDAQ 4,771.9090 -33.3820 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs